Delivery Order SPE2DE24D0013-SPE2D625F0MMU
- Not listed
- The U.S. Defense Logistics Agency, through its Medical Supply Chain division, awarded a $3,638 firm fixed-price delivery order to Cepheid Inc. (UEI: W6HQTMWB9Q28) on May 30, 2025, with an ultimate completion date of June 13, 2025. This delivery order, designated XPCOV2/FLU/RSV-10, carries no set-aside designation and is for molecular diagnostic testing solutions related to COVID-19, influenza, and respiratory syncytial virus detection. The work will be performed at Cepheid's facility in...
- The U.S. Defense Department's Medical Supply Chain awarded a $6,800 firm fixed-price delivery order to Cepheid Inc. (UEI: W6HQTMWB9Q28) for molecular diagnostic solutions related to COVID-19, influenza, and respiratory syncytial virus (RSV) testing. The award, issued on September 19, 2025, with a completion date of September 26, 2025, carries no set-aside designation and will be performed at Cepheid's facility in Sunnyvale, California. This delivery order represents a continuation of the...
- The U.S. Defense Logistics Agency's Medical Supply Chain division awarded a $17,000 firm fixed-price delivery order to Cepheid Inc. (UEI: W6HQTMWB9Q28) on August 19, 2025, for molecular diagnostic solutions related to COVID-19, influenza, and respiratory syncytial virus testing. The contract, designated as XPCOV2/FLU/RSV-10, has an ultimate completion date of August 26, 2025, and will be performed at Cepheid's headquarters in Sunnyvale, California. No small business set-aside was utilized for...
- The U.S. Defense Department's Medical Supply Chain agency awarded a $40.8K firm fixed-price delivery order to Cepheid Inc. (UEI: W6HQTMWB9Q28), a Sunnyvale, California-based manufacturer of molecular diagnostic solutions. The award, issued on July 30, 2025, with an ultimate completion date of August 6, 2025, carries no set-aside designation and covers diagnostic testing solutions related to COVID-19, influenza, and respiratory syncytial virus (RSV) detection. Performance will take place at...
- The Defense Logistics Agency's Medical Supply Chain division awarded a $5,174.64 firm fixed-price delivery order to Cepheid Inc. (UEI: W6HQTMWB9Q28), a Sunnyvale, California-based manufacturer of molecular diagnostic solutions. This delivery order, designated XPCOV2/FLU/RSV-10, has an ultimate completion date of July 30, 2025, and carries no set-aside designation. The contract references diagnostic testing for COVID-19, influenza, and respiratory syncytial virus (RSV), consistent with...
- The U.S. Defense Health Agency, through the Medical Supply Chain, awarded a $40.8K firm fixed-price delivery order to Cepheid Inc. (UEI: W6HQTMWB9Q28) on August 12, 2025, for molecular diagnostic solutions with an ultimate completion date of August 19, 2025. This delivery order, designated 4569068770 and titled XPCOV2/FLU/RSV-10, leverages Cepheid's expertise in infectious disease diagnostics and carries no set-aside designation. The work will be performed at Cepheid's facility in Sunnyvale,...
- The Defense Department's Medical Supply Chain awarded a $57.8K firm fixed-price delivery order to Cepheid Inc. (UEI: W6HQTMWB9Q28) on September 8, 2025, for molecular diagnostic solutions with an ultimate completion date of September 15, 2025. The delivery order, designated XPCOV2/FLU/RSV-10, will be performed in Sunnyvale, California, where Cepheid manufactures its GeneXpert diagnostic systems and associated test kits. This award carries no set-aside designation and represents a continuation of...
- The Defense Logistics Agency's Medical Supply Chain division awarded a $12,694.80 firm fixed-price delivery order to Cepheid Inc. (UEI: W6HQTMWB9Q28) on September 9, 2025, for molecular diagnostic testing solutions. The delivery order, designated XPCOV2/FLU/RSV-10, is scheduled for completion by September 16, 2025, and will be performed at Cepheid's Sunnyvale, California facility. This award carries no set-aside designation and represents a routine procurement under the company's existing...
- The U.S. Defense Department's Medical Supply Chain organization awarded a $2,835 firm fixed-price delivery order to Cepheid Inc. on August 29, 2025, for molecular diagnostic testing solutions related to COVID-19, influenza, and respiratory syncytial virus (RSV) detection. The delivery order, which extends through September 8, 2025, will be performed at Cepheid's facility in Sunnyvale, California. This award carries no small business set-aside designation and represents a continuation of...
- The U.S. Defense Department's Medical Supply Chain awarded a $3,400 firm fixed-price delivery order to Cepheid Inc. (UEI: W6HQTMWB9Q28), a Sunnyvale, California-based manufacturer of molecular diagnostic solutions. This delivery order, issued on August 11, 2025, with an ultimate completion date of August 18, 2025, pertains to XPCOV2/FLU/RSV-10 testing capabilities and carries no set-aside designation. The contract represents work performed under Cepheid's larger indefinite delivery vehicles,...
- SPE2DE24D0013Indefinite Delivery Contract
- SPE2DE24D0013-SPE2D625F0MMUDelivery Order
The Defense Logistics Agency's Medical Supply Chain division awarded a delivery order valued at $3,580 to Cepheid Inc. (UEI: W6HQTMWB9Q28) for molecular diagnostic solutions related to COVID-19, influenza, and respiratory syncytial virus (RSV) testing. The firm fixed-price delivery order, issued on August 7, 2025, is scheduled for completion by August 14, 2025, and will be performed at Cepheid's facility in Sunnyvale, California. This award carries no set-aside designation, indicating it was awarded competitively. This delivery order likely falls under one of Cepheid's existing Indefinite Delivery Vehicle contracts with the Veterans Administration, including the $32.8 billion IDV with VA's Veterans Integrated Service Network 6 or the $2.5 million IDV with VISN 21, both of which authorize procurement of molecular diagnostic testing reagents, assays, and PCR testing capabilities. Cepheid is a specialized manufacturer of molecular diagnostic systems and test kits, and through these ongoing vehicles, continues to supply federal healthcare systems with diagnostic equipment and testing solutions for infectious disease detection across multiple veteran healthcare networks and defense agencies.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.6k | 8/7/25 |